| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d64d6b41c787667d5e33c7d3bc597086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_11e0b3804795e21269a7769254b2ea32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-104
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-7028 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2016-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_272d6008671b3e62d19c5906de845b98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14ce7753d570fc6a6bbe878ac4f591e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa3cde1da8df4d015ba93d54b0938a58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6600253a4d5900e52dec5dcb7494f14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2998afb9af4ed3ec2030f8f2354d4c03 |
| publicationDate |
2018-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3262414-A1 |
| titleOfInvention |
Processes for the diagnosis, prognosis and monitoring of the progression of chronic lymphoid leukaemia (cll) and/or of systemic lupus erythematosus (sle) using membrane stim 1 |
| abstract |
The present invention relates to a process for the diagnosis of systemic lupus erythematosus (SLE) and/or of chronic lymphoid leukaemia (CLL) of a subject who may be suffering therefrom, comprising the in vitro detection of the expression of the fraction of the STIM1 protein located at the cell plasma membrane in a biological sample from human and mice. It also relates to a process for predicting the progression and/or monitoring the progression of CLL and/or of SLE, comprising the in vitro detection of the expression of the fraction of the STIM1 protein located at the cell plasma membrane. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3715848-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020193450-A1 |
| priorityDate |
2015-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |